Literature DB >> 33441438

Moderate Exercise Inhibits Age-Related Inflammation, Liver Steatosis, Senescence, and Tumorigenesis.

Arianna Bianchi1, Letizia Marchetti1, Zoe Hall2, Henrique Lemos1, Michele Vacca3, Hannah Paish1, Kile Green1, Bronte Elliott4, Dina Tiniakos1, João F Passos5, Diana Jurk5, Derek A Mann1, Caroline L Wilson6.   

Abstract

Age-related chronic inflammation promotes cellular senescence, chronic disease, cancer, and reduced lifespan. In this study, we wanted to explore the effects of a moderate exercise regimen on inflammatory liver disease and tumorigenesis. We used an established model of spontaneous inflammaging, steatosis, and cancer (nfkb1-/- mouse) to demonstrate whether 3 mo of moderate aerobic exercise was sufficient to suppress liver disease and cancer development. Interventional exercise when applied at a relatively late disease stage was effective at reducing tissue inflammation (liver, lung, and stomach), oxidative damage, and cellular senescence, and it reversed hepatic steatosis and prevented tumor development. Underlying these benefits were transcriptional changes in enzymes driving the conversion of tryptophan to NAD+, this leading to increased hepatic NAD+ and elevated activity of the NAD+-dependent deacetylase sirtuin. Increased SIRT activity was correlated with enhanced deacetylation of key transcriptional regulators of inflammation and metabolism, NF-κB (p65), and PGC-1α. We propose that moderate exercise can effectively reprogram pre-established inflammatory and metabolic pathologies in aging with the benefit of prevention of disease.
Copyright © 2021 The Authors.

Entities:  

Year:  2021        PMID: 33441438      PMCID: PMC7851741          DOI: 10.4049/jimmunol.2001022

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Obesity and aging diminish sirtuin 1 (SIRT1)-mediated deacetylation of SIRT3, leading to hyperacetylation and decreased activity and stability of SIRT3.

Authors:  Sanghoon Kwon; Sunmi Seok; Peter Yau; Xiaoling Li; Byron Kemper; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

Review 2.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

3.  SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310.

Authors:  Karin M Rothgiesser; Süheda Erener; Susanne Waibel; Bernhard Lüscher; Michael O Hottiger
Journal:  J Cell Sci       Date:  2010-11-16       Impact factor: 5.285

4.  Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity.

Authors:  Yuchen Chien; Claudio Scuoppo; Xiaowo Wang; Xueping Fang; Brian Balgley; Jessica E Bolden; Prem Premsrirut; Weijun Luo; Agustin Chicas; Cheng S Lee; Scott C Kogan; Scott W Lowe
Journal:  Genes Dev       Date:  2011-10-06       Impact factor: 11.361

5.  Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes.

Authors:  Meri Kaustio; Emma Haapaniemi; Helka Göös; Timo Hautala; Giljun Park; Jaana Syrjänen; Elisabet Einarsdottir; Biswajyoti Sahu; Sanna Kilpinen; Samuli Rounioja; Christopher L Fogarty; Virpi Glumoff; Petri Kulmala; Shintaro Katayama; Fitsum Tamene; Luca Trotta; Ekaterina Morgunova; Kaarel Krjutškov; Katariina Nurmi; Kari Eklund; Anssi Lagerstedt; Merja Helminen; Timi Martelius; Satu Mustjoki; Jussi Taipale; Janna Saarela; Juha Kere; Markku Varjosalo; Mikko Seppänen
Journal:  J Allergy Clin Immunol       Date:  2017-01-21       Impact factor: 10.793

Review 6.  The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications.

Authors:  Zheqiong Tan; Xiangjian Luo; Lanbo Xiao; Min Tang; Ann M Bode; Zigang Dong; Ya Cao
Journal:  Mol Cancer Ther       Date:  2016-04-15       Impact factor: 6.261

7.  Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Authors:  Mazen Noureddin; Katherine P Yates; Ivana A Vaughn; Brent A Neuschwander-Tetri; Arun J Sanyal; Arthur McCullough; Raphael Merriman; Bilal Hameed; Edward Doo; David E Kleiner; Cynthia Behling; Rohit Loomba
Journal:  Hepatology       Date:  2013-10-02       Impact factor: 17.425

8.  NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma.

Authors:  C L Wilson; D Jurk; N Fullard; P Banks; A Page; S Luli; A M Elsharkawy; R G Gieling; J Bagchi Chakraborty; C Fox; C Richardson; K Callaghan; G E Blair; N Fox; A Lagnado; J F Passos; A J Moore; G R Smith; D G Tiniakos; J Mann; F Oakley; D A Mann
Journal:  Nat Commun       Date:  2015-04-16       Impact factor: 14.919

Review 9.  DNA damage in telomeres and mitochondria during cellular senescence: is there a connection?

Authors:  João F Passos; Gabriele Saretzki; Thomas von Zglinicki
Journal:  Nucleic Acids Res       Date:  2007-11-05       Impact factor: 16.971

10.  NFκB1 is essential to prevent the development of multiorgan autoimmunity by limiting IL-6 production in follicular B cells.

Authors:  Elisha de Valle; George Grigoriadis; Lorraine A O'Reilly; Simon N Willis; Mhairi J Maxwell; Lynn M Corcoran; Evelyn Tsantikos; Jasper K S Cornish; Kirsten A Fairfax; Ajithkumar Vasanthakumar; Mark A Febbraio; Margaret L Hibbs; Marc Pellegrini; Ashish Banerjee; Philip D Hodgkin; Axel Kallies; Fabienne Mackay; Andreas Strasser; Steve Gerondakis; Raffi Gugasyan
Journal:  J Exp Med       Date:  2016-03-28       Impact factor: 14.307

View more
  4 in total

Review 1.  Reframing How Physical Activity Reduces The Incidence of Clinically-Diagnosed Cancers: Appraising Exercise-Induced Immuno-Modulation As An Integral Mechanism.

Authors:  Annabelle Emery; Sally Moore; James E Turner; John P Campbell
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

Review 2.  Telomere dysfunction in ageing and age-related diseases.

Authors:  Francesca Rossiello; Diana Jurk; João F Passos; Fabrizio d'Adda di Fagagna
Journal:  Nat Cell Biol       Date:  2022-02-14       Impact factor: 28.213

Review 3.  NAFLD-Associated HCC: Progress and Opportunities.

Authors:  Daniel Geh; Quentin M Anstee; Helen L Reeves
Journal:  J Hepatocell Carcinoma       Date:  2021-04-08

Review 4.  Cellular senescence: the good, the bad and the unknown.

Authors:  Weijun Huang; LaTonya J Hickson; Alfonso Eirin; James L Kirkland; Lilach O Lerman
Journal:  Nat Rev Nephrol       Date:  2022-08-03       Impact factor: 42.439

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.